1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > Skin Cancer-Pipeline Insights, 2017

Skin Cancer-Pipeline Insights, 2017

  • January 2017
  • -
  • Delve Insight

Summary

Table of Contents


DelveInsight’s, “ Skin Cancer-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Skin Cancer. The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. DelveInsight’s Report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Skin Cancer. DelveInsight’s Report also assesses the Skin Cancer therapeutics by Monotherapy, Combination products, Molecule type and Route of Administration.

Please note:This report requires certain updates. We have all the information available but require 3 business days to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated indication.

Scope

- The report provides competitivepipeline landscape of Skin Cancer
- The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
- Coverage of the Skin Cancer pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
- The report reviews key players involved in the therapeutics development for Skin Cancer and also provide company profiling
- The report also gives the information of dormant and discontinued pipeline projects
- Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
- Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type

Please note: this report requires certain updates. We have all the information available but require 3 business days to complete the process and ensure it is as up-to-date as possible.


Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
Get This Report
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Global Skin Cancer Therapeutics Market - Growth, Trends and Forecasts (2017 - 2022)

Global Skin Cancer Therapeutics Market - Growth, Trends and Forecasts (2017 - 2022)

  • $ 4250
  • Industry report
  • February 2017
  • by Mordor Intelligence LLP

The global skin cancer treatment market is expected to grow at a CAGR of XX% during the forecast period 2016-2021. The market was valued at USD XX million in 2015 and is forecasted to reach USD XX million ...

European Cancer Therapies Market - Growth, Trends and Forecasts (2017 - 2022)

European Cancer Therapies Market - Growth, Trends and Forecasts (2017 - 2022)

  • $ 3850
  • Industry report
  • February 2017
  • by Mordor Intelligence LLP

The Europe market for Cancer therapy market has been estimated at USD 6.024 billion for the year 2014 and is projected to reach USD 12.54 billion by the end of 2020 at a CAGR of 13 % during the forecast ...

2017-2021 France Tumor Marker Testing Market: Emerging Opportunities and Growth Strategies for Suppliers

2017-2021 France Tumor Marker Testing Market: Emerging Opportunities and Growth Strategies for Suppliers

  • $ 4350
  • Industry report
  • February 2017
  • by Venture Planning Group

Highlights Comprehensive 585-page analysis of the French tumor marker testing market.Major issues pertaining to the French laboratory practice, as well as key economic, regulatory, demographic, social ...


Download Unlimited Documents from Trusted Public Sources

Lymphoma Statistics in Germany

  • March 2017
    167 pages
  • Lymphoma  

    Cancer  

    Leukemia  

  • Germany  

    Europe  

    United States  

View report >

OTC Industry in the US

  • March 2017
    29 pages
  • Prostate Cancer  

    Clinical Trial  

    Therapy  

  • United States  

View report >

Cancer Statistics in the UK

  • March 2017
    4 pages
  • Cancer  

  • United Kingdom  

    Europe  

View report >

Related Market Segments :

Skin Cancer

ref:plp2017

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.